While Healthequity Inc has overperformed by 1.73%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HQY rose by 1.50%, with highs and lows ranging from $116.65 to $74.07, whereas the simple moving average jumped by 2.51% in the last 200 days.
On December 09, 2025, Barclays started tracking Healthequity Inc (NASDAQ: HQY) recommending Overweight. A report published by BMO Capital Markets on November 13, 2025, Initiated its previous ‘Market Perform’ rating for HQY. RBC Capital Mkts also rated HQY shares as ‘Outperform’, setting a target price of $112 on the company’s shares in an initiating report dated May 22, 2025. Raymond James March 25, 2025d the rating to Strong Buy on March 25, 2025, and set its price target from $120 to $115. Mizuho initiated its ‘Outperform’ rating for HQY, as published in its report on December 04, 2024. Goldman’s report from November 15, 2024 suggests a price prediction of $108 for HQY shares, giving the stock a ‘Neutral’ rating. JMP Securities also rated the stock as ‘Mkt Outperform’.
Analysis of Healthequity Inc (HQY)
Further, the quarter-over-quarter increase in sales is 7.23%, showing a positive trend in the upcoming months.
One of the most important indicators of Healthequity Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 9.01% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 4.13, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and HQY is recording 879.83K average volume. On a monthly basis, the volatility of the stock is set at 3.59%, whereas on a weekly basis, it is put at 4.14%, with a gain of 1.80% over the past seven days. Furthermore, long-term investors anticipate a median target price of $121.38, showing growth from the present price of $97.39, which can serve as yet another indication of whether HQY is worth investing in or should be passed over.
How Do You Analyze Healthequity Inc Shares?
The Health Information Services market is dominated by Healthequity Inc (HQY) based in the USA. When comparing Healthequity Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 44.63, there is a growth in quarterly earnings of 824.42%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.26%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 106.07% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
HQY shares are owned by institutional investors to the tune of 106.07% at present.
